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Abstract
Background: Recent advances in liquid chromatography-mass spectrometry (LC-MS) technology have led to more
effective approaches for measuring changes in peptide/protein abundances in biological samples. Label-free LC-MS
methods have been used for extraction of quantitative information and for detection of differentially abundant
peptides/proteins. However, difference detection by analysis of data derived from label-free LC-MS methods
requires various preprocessing steps including filtering, baseline correction, peak detection, alignment, and
normalization. Although several specialized tools have been developed to analyze LC-MS data, determining the
most appropriate computational pipeline remains challenging partly due to lack of established gold standards.
Results: The work in this paper is an initial study to develop a simple model with “presence” or “absence”
condition using spike-in experiments and to be able to identify these “true differences” using available software
tools. In addition to the preprocessing pipelines, choosing appropriate statistical tests and determining critical
values are important. We observe that individual statistical tests could lead to different results due to different
assumptions and employed metrics. It is therefore preferable to incorporate several statistical tests for either
exploration or confirmation purpose.
Conclusions: The LC-MS data from our spike-in experiment can be used for developing and optimizing LC-MS
data preprocessing algorithms and to evaluate workflows implemented in existing software tools. Our current work
is a stepping stone towards optimizing LC-MS data acquisition and testing the accuracy and validity of
computational tools for difference detection in future studies that will be focused on spiking peptides of diverse
physicochemical properties in different concentrations to better represent biomarker discovery of differentially
abundant peptides/proteins.
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Background
Changes in the abundance of particular proteins/pep-
tides or their modifications can influence the state of an
organism. The primary focus of biomarker discovery
studies in proteomics is to study changes in peptide/
protein abundances that are generated in response to a
perturbation, disease, morphogenesis, toxicity, or other
cell stress in a given biological system [1-4]. Liquid
chromatography-mass spectrometry (LC-MS) has been
an indispensable tool for profiling small differences in
expression level of peptides/proteins in complex biologi-
cal medium [5-8]. This is due to the development of
soft ionization techniques and tandem mass spectrome-
try, which makes it a sensitive tool for detecting and
identifying peptides. Data-dependent acquisition (DDA)
or information-dependent acquisition (IDA) of tandem
mass spectra has allowed complex proteomes to be cata-
loged as well [9]. A typical LC-MS-based proteomics
study includes sample preparation, separation of pep-
tides/proteins on a single or multiple HPLC columns,
ionization of chromatographic elutes by ESI source
(electrospray ionization), detection of multiple charged
peptides/proteins by mass spectrometry and subsequent
data analysis.
Difference detection by LC-MS method can be
achieved by either using isotope coded affinity tag
method (ICAT) and other isotope labeling techniques
such as iTRAQ, O
18 and N
15 [10-12] to encode relative
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ples or using a label-free approach. Although isotope
labeling methods have been widely used for both relative
and absolute quantification of peptides abundance, sev-
eral limitations remain including limited number of
samples allowed, artifacts during labeling process, lim-
ited availability of isotope references, etc. [13,14]. Mean-
while, label-free methods have grown as an alternative
for measuring protein/peptide abundances in biomarker
discovery studies.
Label-free methods have been gaining a lot of atten-
tion for measuring differential protein expression as
they are cost effective and yield a wide dynamic range.
These methods do not require labeling of samples and
involve simpler sample preparation protocols than label-
ing methods. Label-free difference detection methods
have been used based on various features including
spectral count [15], sequence coverage [16], peptide
count [17], and precursor ion intensity [18-22]. The first
three methods provide relative abundance information
on the basis of MS/MS fragmentation. However, these
methods tend to discard low abundant ions that are not
typically selected at survey scan (MS1) level for MS/MS
fragmentation. Alternatively, a direct comparison of pre-
cursor ions, where all ions at MS1 level are analyzed,
can potentially capture low abundant ions. However,
this approach requires that preprocessing steps such as
peak detection, filtering, alignment, and normalization
are appropriately handled with care.
An LC-MS run contains retention time information in
a chromatogram, m/z value in MS spectrum, and rela-
tive ion abundance for each particular ion. MS signals
of all ions across the whole chromatographic duration
are formatted as a three-dimensional map that defines
the LC-MS data. With an increasing interest in label-
free quantification, several software tools have been
made available for LC-MS data analysis including msIn-
s p e c t[ 2 3 ] ,M Z m i n e2[ 2 4 ] ,P r o g e n e s i sL C - M S( N o n -
Linear Dynamics, United Kingdom) [25], and XCMS
[26]. While all tools are involved in preprocessing LC-
MS data at some level [27], they either have been opti-
mized for certain platforms or have their own computa-
tional requirements on how the data should be
processed. Each tool implements a different set of algo-
rithms in its workflow characterized by its set of
strengths and limitations. While some workflows per-
form well on data preprocessing steps, others focus pri-
marily on statistical and machine learning methods for
difference detection or visualization. The spike-in
experiment presented in this paper allows us to evaluate
such workflows. Figure 1 illustrates the experimental
design that involves two groups of samples: (i) serum
samples with spike-in peptides, and (ii) serum samples
alone. LC-MS data were generated by QTOF mass
spectrometer equipped with nano-ionization source and
hyphenated with nano-Acquity UPLC system. Four soft-
ware tools (msInspect, MZmine 2, Progenesis LC-MS,
and XCMS) were applied for LC-MS data analysis to
evaluate workflows implemented. The software tools
were chosen for flexibility provided by their modular
workflows to assess each pipeline explicitly and their
ability to export information on extracted features for
further comparison and statistical analysis.
Results and discussion
Two groups of data were generated from five serum
samples obtained from five healthy individuals. The first
g r o u po fd a t aw a sd e r i v e df r o mt h ef i v es e r u ms a m p l e s
mixed with known concentration of spike-in peptides.
The second group of data was obtained from the five
serum samples alone. In the first group, nine MassPrep
peptides (designated as Peptides 1-9 in Table 1) were
added prior to acquisition of LC-MS data (Figure 1).
The data are available at http://omics.georgetown.edu/
massprep.html. The raw LC-MS data were exported as .
wiff files and converted to mzXML format using mzWiff
(version 4.2.1) or msconvert from ProteoWizard (version
2.2) [28] before importing them into the software tools.
Due to the compatibility issue between converters and
analysis tools, data converted by mzWiff were analyzed
by MZmine 2 while data converted by msconvert were
analyzed by the other three tools. Figure 2 demonstrates
the presence/absence contrast between the two groups
with the base peak chromatograms of the spiked Mas-
sPrep peptides in m/z accuracy ± 50 ppm and retention
time tolerance of 3 min. Parameters for each preproces-
sing pipelines were chosen to identify as many spike-in
peptides as possible.
At the feature detection level, all the 13 features can
be detected in at least one of the four software tools.
For difference detection at MS1 level, we calculate the
p-value of t-test on each detected feature and apply
multiple testing correction [29]. Features that satisfy the
criterion of q- v a l u e<0 . 0 5a n df o l dc h a n g e( F C )>1 0
are selected as significantly different between the two
groups. Prior to this statistical analysis for difference
detection, we retained only the features that were
detected in at least two replicates in each group. Among
the features detected by msInspect, 6,525 features were
considered for statistical analysis, of which 2,099 had q-
value < 0.05 and FC > 10. From 12,092 features
obtained by MZmine 2, 539 features yielded q-value <
0.05 and FC > 10. From 8,415 features obtained by Pro-
genesis LC-MS, 467 features had a q-value < 0.05 and
FC > 10. Among 8,703 features from XCMS, 66 features
had q-value < 0.05 and FC > 10. Table 2 presents the
number of features selected from each of the four soft-
ware tools following statistical analysis. The table
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tides and which resulted in significant changes (q-value
< 0.05 and FC > 10) in comparing MS1 level LC-MS
data from the two groups. Also, the table shows the
ranking of the peptides on the basis of q-values and FC
as well as the sensitivity and number of false positives of
the results obtained in analyzing the data preprocessed
by each of the four software tools.
As shown in Table 2, six features (1, 2, 3a, 3b, 4, and
5b) were selected as differentially abundant (q-value <
0.05, FC > 10) by all four software tools while three fea-
tures (7a, 8, and 9a) were selected by none of the
Figure 1 Spike-in experiment to evaluate analysis of LC-MS data generated by a label-free LC-MS method. The experiment design
involves two groups of samples: (i) serum samples with spike-in peptides, and (ii) serum samples alone. LC-MS data were generated by UPLC-
QTOF mass spectrometer. Four software tools (msInspect, MZmine 2, Progenesis LC-MS, and XCMS) were applied for LC-MS data analysis to
evaluate workflows implemented.
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and 9b) were selected by at least one software tool.
While msInspect and Progenesis LC-MS yielded rela-
tively better sensitivity than XCMS and MZmine 2, the
latter two got fewer false positives than the former two.
However, it should be emphasized that by selecting
more stringent parameters for msInspect and Progenesis
LC-MS and focusing only on the high abundance pep-
tides, comparable (or even fewer) number of false posi-
tives could be achieved. Our evaluation of software tools
in this study highlights the challenges of using these
tools for identifying low intensity features and boosting
of sensitivity. This becomes more critical in biomarker
discovery studies, where identifying low abundance fea-
tures is very relevant. In general, without any informa-
tion regarding features at MS1 level, it would be
difficult to select parameters for each software tool
properly. Using the MS/MS information of the Mas-
sPrep peptides and examining the associated MS1 pro-
files, the study design provides some guidelines for
better extracting features of interests. Missing value is
another critical issue for difference detection, particu-
larly affecting low abundance peptides considerably [30].
Features detected in only a subset of the replicates (e.g.,
Features 7a, 8, and 9a as depicted in Figure 2) may fail
to pass statistical tests and not be selected as differen-
tially abundant.
In addition to using parametric statistical test (q-
values) and fold change (FC), difference detection results
were also confirmed using the Wilcoxon rank-sum test
(p < 0.05), which is a non-parametric statistical hypoth-
esis test. Although it is always preferable to check which
assumption holds true prior to using a specific statistical
test, we chose to examine the results by applying both
parametric and non-parametric tests due to small sam-
ple size and a large number of features involved in this
study. A summary of the results is presented in Table 3.
We observed that the combination of fold change, para-
metric test, and non-parametric test significantly
reduces the number of false positives without signifi-
cantly affecting the sensitivity.
Conclusions
We present a spike-in experiment to evaluate the per-
formance of four software tools in detecting “true differ-
ences” in peptide abundance between two datasets
acquired using a label-free LC-MS method. The perfor-
mance of each tool is assessed by their ability to detect
spike-in peptides as true differences between two groups
on the basis of MS1-level ion abundance measurements.
We observe that selection of appropriate parameters for
feature detection in using each software tool is very
important. Modular workflows are desired to assess the
parameters for each pipeline explicitly. In addition to
the preprocessing pipelines, choosing appropriate statis-
tical tests and determining suitable significance level are
not trivial problems. We observe that individual statisti-
cal tests could lead to different results due to different
assumption and employed metrics. It is therefore prefer-
able to incorporate several statistical tests for either
exploration or confirmation purpose. The LC-MS data
from our spike-in experiment can be used to assess the
statistical power of different testing methods.
While Progenesis LC-MS supports a complete pipeline
for label-free proteomics and provides information on
conflicting peptides identified for the same feature, cer-
tain parameters for peak grouping are not available for
tuning/optimization. Whereas the other three software
tools provide the flexibility for software parameterization
and extended analysis, they lack an identification mod-
ule. Each step in the preprocessing workflow is impor-
tant as highlighted by the analysis results. While
developing a flawless workflow seems difficult, it would
be extremely beneficial if preprocessing steps from dif-
ferent tools could be unified into a single workflow. At
present, most software tools do not provide such flex-
ibility which prevents the possibility to borrow strength
with each other.
As shown in Table 3, all the 13 expected features that
represent the nine MassPrep peptides can be detected
by at least one software tool. Of these, between seven
and nine features were selected as significantly different
between the two groups (Table 2). At peptide level,
Table 1 The sequence information of the nine selected MassPrep peptides
Peptide no. Component name Molecular weight (g/mol) pKa Peptide sequence
1 RASG-1 1000.4938 9.34 RGDSPASSKP
2 Angiotensin frag 1-7 898.4661 7.35 DRVYIHP
3 Bradykinin 1059.5613 12.00 RPPGFSPFR
4 Angiotensin II 1045.5345 7.35 DRVYIHPF
5 Angiotensin I 1295.6775 7.51 DRVYIHPFHL
6 Renin substrate 1757.9253 7.61 DRVYIHPFHLLVYS
7 Enolase T35 1871.9604 7.34 WLTGPQLADLYHSLMK
8 Enolase T37 2827.2806 3.97 YPIVSIEDPFAEDDWEAWSHFFK
9 Melitin 2845.7381 12.06 GIGAVLKVLTTGLPALISWIKRKRQQ
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m/z and retention time values match with those of the MassPrep peptides, in comparison of serum with spike-in peptides (+MassPrep) and
serum alone (-MassPrep) groups.
Tuli et al. Proteome Science 2012, 10:13
http://www.proteomesci.com/content/10/1/13
Page 5 of 11Table 2 Performance comparison of msInspect, MZmine 2, Progenesis LC-MS, and XCMS.
msInspect (Number of selected features = 2099, sensitivity = 9/13, FP = 2090)
Feature No. Peptide m/z (charge) q-value (rank) FC (rank)
1 RGDSPASSKP 501.25 (2) 0.0139 (38) Inf (1)
2 DRVYIHP 450.23 (2) 0.0114 (1) Inf (1)
3a RPPGFSPFR 530.78 (2) 0.0164 (43) 90.5 (1911)
3b RPPGFSPFR 354.19 (3) 0.0114 (1) 32.5 (1935)
4 DRVYIHPF 523.77 (2) 0.0166 (220) 47.8 (1921)
5a DRVYIHPFHL 648.84 (2) 0.0120 (28) Inf (1)
5b DRVYIHPFHL 432.89 (3) 0.0126 (31) Inf (1)
6 DRVYIHPFHLLVYS 586.98 (3) 0.0164 (43) Inf (1)
7a WLTGPQLADLYHSLMK 624.99 (3)
7b WLTGPQLADLYHSL(M)K 630.35 (3) 0.0164 (43) Inf (1)
8 YPIVSIEDPFAEDDWEAWSHFFK 943.43 (3)
9a GIGAVLKVLTTGLPALISWIKRKRQQ 712.43 (4)
9b GIGAVLKVLTTGLPALISWIKRKRQQ 570.15 (5)
MZmine 2 (Number of selected features = 539, sensitivity = 7/13, FP = 532)
Feature No. Peptide m/z (charge) q-value (rank) FC (rank)
1 RGDSPASSKP 501.25 (2) 0.0278 (18) 40.0 (243)
2 DRVYIHP 450.23 (2) 0.0271 (1) 97.9 (152)
3a RPPGFSPFR 530.78 (2) 0.0271 (1) 54.1 (202)
3b RPPGFSPFR 354.19 (3) 0.0271 (1) 41.4 (238)
4 DRVYIHPF 523.77 (2) 0.0278 (18) 204.9 (107)
5a DRVYIHPFHL 648.84 (2) 0.0399 (173) 11.2 (509)
5b DRVYIHPFHL 432.89 (3) 0.0301 (53) 9636.3 (34)
6 DRVYIHPFHLLVYS 586.98 (3)
7a WLTGPQLADLYHSLMK 624.99 (3)
7b WLTGPQLADLYHSL(M)K 630.35 (3)
8 YPIVSIEDPFAEDDWEAWSHFFK 943.43 (3)
9a GIGAVLKVLTTGLPALISWIKRKRQQ 712.43 (4)
9b GIGAVLKVLTTGLPALISWIKRKRQQ 570.15 (5)
Progenesis LC-MS (Number of selected features = 467, sensitivity = 8/13, FP = 459)
Feature No. Peptide m/z (charge) q-value (rank) FC (rank)
1 RGDSPASSKP 501.25 (2) 0.0308 (180) 73.0 (178)
2 DRVYIHP 450.23 (2) 0.0103 (1) 33.1 (240)
3a RPPGFSPFR 530.78 (2) 0.0146 (4) 32.4 (243)
3b RPPGFSPFR 354.19 (3) 0.0103 (1) 46.9 (210)
4 DRVYIHPF 523.77 (2) 0.0146 (4) 65.8 (184)
5a DRVYIHPFHL 648.84 (2)
5b DRVYIHPFHL 432.89 (3) 0.0146 (4) Inf (1)
6 DRVYIHPFHLLVYS 586.98 (3)
7a WLTGPQLADLYHSLMK 624.99 (3)
7b WLTGPQLADLYHSL(M)K 630.35 (3) 0.0222 (33) 50.6 (201)
8 YPIVSIEDPFAEDDWEAWSHFFK 943.43 (3)
9a GIGAVLKVLTTGLPALISWIKRKRQQ 712.43 (4)
9b GIGAVLKVLTTGLPALISWIKRKRQQ 570.15 (5) 0.0441 (365) Inf (1)
XCMS (Number of selected features = 66, sensitivity = 7/13, FP = 59)
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were selected as differentially abundant at charge +3
and +5, respectively. For Peptide 9, Feature 9b with
charge +5 was observed to be the most prominent ion.
T h ei d e n t i t yo ft h i sf e a t u r ew a sc o n f i r m e db a s e do n
MS/MS data collected on its 3rd isotopic peak. A low
resolution setting on Q1 quadropole allowed all isotopes
associated with a given precursor to be transmitted
through the quadropole, thereby generating a 3rd isoto-
pic peak for Feature 9b. Although the IDA experiment
is set to monitor peaks with charge states +2 to +4,
sometimes when the software cannot determine the
charge state, it will consider the peak as unknown and
that peak will be submitted for MS/MS if its intensity is
above a pre-specified intensity threshold. We believe
that Feature 9b was selected for MS/MS analysis,
because it was tagged unknown. Similarly for Peptide 7,
a modified peptide sequence (Feature 7b, methionine
oxidation at residue #15 that has a mass difference of 16
Da) was observed to be prominent. On the other hand,
while Peptide 8 was easily detected and identified in
absence of serum, no such matching feature was
observed consistently in the spiked-in serum group. A
possible explanation is ion suppression from co-eluting
interferences in serum sample during ESI. While Fea-
tures 7a, 8 and 9a may appear to be non-informative
from the point of software evaluation, they highlight an
often forgotten issue with LC-MS data, where the inabil-
ity to detect an analyte does not necessarily imply its
absence from the sample. Since Feature 8 (representing
Peptide 8) only had a low ion intensity and was detected
in only a subset of the samples in presence of serum,
further optimization at sample preparation and LC-MS
gradient level is needed. Differential mass spectrometry
combined with targeted MS/MS analysis of only identi-
fied differences may save both computation time and
human effort compared to shotgun proteomics
approaches. The work in this paper is an initial study to
develop a simple model with “presence” or “absence”
condition using spike-in experiments and to identify
Table 2 Performance comparison of msInspect, MZmine 2, Progenesis LC-MS, and XCMS. (Continued)
Feature No. Peptide m/z (charge) q-value (rank) FC (rank)
1 RGDSPASSKP 501.25 (2) 0.0437 (3) 40.0 (8)
2 DRVYIHP 450.23 (2) 0.0224 (1) 25.3 (19)
3a RPPGFSPFR 530.78 (2) 0.0437 (3) 52.2 (7)
3b RPPGFSPFR 354.19 (3) 0.0437 (3) 38.0 (9)
4 DRVYIHPF 523.77 (2) 0.0437 (3) 137.8 (2)
5a DRVYIHPFHL 648.84 (2)
5b DRVYIHPFHL 432.89 (3) 0.0437 (3) 488.4 (1)
6 DRVYIHPFHLLVYS 586.98 (3)
7a WLTGPQLADLYHSLMK 624.99 (3)
7b WLTGPQLADLYHSL(M)K 630.35 (3) 0.0491 (66) 17.9 (27)
8 YPIVSIEDPFAEDDWEAWSHFFK 943.43 (3)
9a GIGAVLKVLTTGLPALISWIKRKRQQ 712.43 (4)
9b GIGAVLKVLTTGLPALISWIKRKRQQ 570.15 (5)
The comparison is based on q-value and fold-change (FC) of spike-in peptides in comparing spike-in serum samples versus serum samples. Ranking is provided
on q-values and FC. The number of differentially abundant features, sensitivity, and false positives (FP) are calculated based on the criterion of q-value < 0.05
and FC > 10
Table 3 Summary of difference detection results by combining different statistical tests.
msInspect MZmine 2 Progenesis XCMS
Total number of features detected 31168 (12) 12271 (12) 9267 (9) 21486 (13)
Number of features used for statistical analysis 6525 (9) 12092 (9) 8415 (9) 8703 (10)
t-test (q < 0.05) 4824 (9) 3505 (7) 4465 (9) 1896 (7)
Wilcoxon rank-sum test (p < 0.05) 603 (8) 1318 (6) 1584 (8) 812 (8)
t-test (q < 0.05) + Wilcoxon (p < 0.05) 603 (8) 967 (6) 1379 (8) 672 (7)
t-test (q < 0.05) + FC (> 10) 2099 (9) 539 (7) 467 (8) 66 (7)
t-test (q < 0.05) + Wilcoxon (p < 0.05) + FC (> 10) 388 (8) 323 (6) 238 (7) 55 (7)
The total number of features detected and those satisfying different criteria, i.e., t-test with multiple hypothesis testing (q-value < 0.05), Wilcoxon sum-rank test
(p-value < 0.05), and fold change (FC > 10). The plus symbol denotes the combination of different criteria. Only features present in at least two replicates in each
group were used for statistical analysis. The numbers in parenthesis indicate the number of MassPrep features identified in each category. We found six features
(Features 1, 2, 3a, 3b, 4, and 5b) identified as differentially abundant by each of the four software tools in each category
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The LC-MS data from our spike-in experiment can be
used for developing and optimizing LC-MS data prepro-
cessing algorithms and to evaluate workflows implemen-
ted in existing software tools. Current work as a
stepping stone can help optimize the LC-MS data acqui-
sition and test the accuracy and validity of computa-
tional tools for difference detection in future studies
that will be focused on spiking peptides of diverse physi-
cochemical properties in different concentrations to bet-
ter represent the biomarker discovery of differentially
abundant peptides/proteins.
Methods
Sample collection and materials
Serum samples were obtained from five healthy indivi-
duals after centrifugation of blood samples at 1,000 g
for 15 min. Samples of serum were stored at -80°C and
allowed to thaw on ice at room temperature prior to
analysis. Acetonitrile and Acetone were purchased from
Fisher Scientific. Tris (2-carboxyethyl) phosphine
(TCEP), methyl methanethiosulfonate (MMTS), Trypsin
(human pancreas) were purchased from sigma Aldrich.
Protein depletion and digestion
Abundant proteins such as albumin obscure separation
and detection of low abundant proteins in serum. It is
common to deplete serum of high abundant proteins
such that low abundant proteins can be easily detected.
For our study, we depleted 60 μLo fh u m a ns e r u mo f
Immunoglobulin G (IgG) and Albumin using Aurum
serum protein mini columns as described in BioRad
protocol [31]. Depleted serum was collected as the
unbound elute by centrifuging the column at 10,000 g.
Protein concentration was determined by Bradford
assay. After acetone precipitation, 100 μgo fd e p l e t e d
serum was set for trypsin digestion. Samples were
reduced with 50 mM tris (2-carboxyethyl) phosphine
(TCEP) at 60°C for 60 min. After cooling to room tem-
perature, the sample was alkylated using 0.2 mM methyl
methanethiosulfonate (MMTS) at 37°C for 30 min.
Trypsin was added (protein:enzyme ratio of 50:1) into
protein solution and incubated at 37°C for 3 h. After
that, trypsin was added one more time into the previous
digestion mixture allowed for overnight incubation at
37°C. The digested samples were further cleaned using
Reverse phase Macrospin column (NestGroup, Inc.),
speedvac dried at 40°C, and reconstituted in mobile
phase A solvent (0.1% formic acid in H2O, 2% ACN)
prior to injection.
LC-MS data acquisition
Two groups of data were generated from five serum
samples obtained from five healthy individuals. The
first group of data was derived from the five serum
samples mixed with known concentration of spike-in
peptides while the second group of data was obtained
from the five serum samples alone. Both groups of
data were acquired by the same LC-MS method. In the
first group, nine MassPrep peptides (designated as
Peptides 1-9 in Table 1) were added prior to acquisi-
tion of LC-MS data (Figure 1). The MassPrep peptide
mixture is a careful selection of nine peptides with a
wide range of polarities, and isoelectric points (pI)
(Table 1). These peptides were preferred as they come
with a predictable retention behavior and elution order
as well as span a broad chromatographic time range.
The concentration of the MassPrep peptides (1 pmol/
μL) was selected and injection volume was 1 μL. Dif-
ferent concentrations of MassPrep peptides (0.05, 0.1
and 0.5 pmole/μL) were also evaluated (data not
shown). MassPrep peptides mixture with concentration
of 1 pmole/μL showed the minimal intensity that
would not swamp the MS signals of serum peptides in
LC-MS acquisition. This amount of peptides was also
used in other spike-in studies [32]. There are other
available LC-MS datasets with spike-in peptides. List-
garten et al. [33] simulated a contrast between the
“presence” and “absence” conditions of spike-in pep-
tides similar to our effort, but they generated the
ground truth by processing the MS1 data rather than
referring to the MS/MS identification results. Another
dataset by Mueller et al. [34] was designed for a sce-
nario of different concentrations of six proteins. How-
ever, their standard solutions were mixed with isolated
human serum peptides that may not fully reflect the
complexity of serum samples. In addition, no biological
replicates were considered in the two datasets.
Chromatographic separation was performed on
Waters NanoACQUITY system using BEH C18 column:
75 μm × 150 mm, 1.7 μm particle size that was equili-
brated with 99% mobile phase A (0.1% formic acid in
H2O, 2% ACN) and 1% mobile phase B (0.1% formic
acid in acetonitrile, 2% H2O). The protein digest was
preloaded on a nanoACQUITY UPLC Symmetry C18
trap column (180 μm × 20 mm) before separation. The
column and the autosampler were maintained at a tem-
perature of 40°C and 4°C respectively. A 180 min gradi-
ent elution (in a 240 min run) was performed at 300
nL/min flow rate as following: maintain 99% mobile
phase A for the first 20 min, change organic solvent
composition to 80% mobile phase B in 180 min, then
increase to 99% B in 15 min and equilibrated to 99% A
and for 25 min. The nanoACQUITY UPLC was con-
nected to QTOF-MS (AB Sciex QSTAR Elite) through
nano-electrospray ionization source. The automated sys-
tem ensured reproducible loading of samples using LC-
autosampler.
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two ions of m/z 879.9723 and m/z 110.0713 using por-
cine rennin substrate tetradecapeptide (1 μMi n
30:70:0.1 (v/v/v) acetonitrile:water:formic acid). After
calibration, resolution was obtained above 10,000 in
FWHM, mass accuracy less than 10 ppm and ion inten-
sity above 2,000. MS settings were as follows: Ionspray
voltage (IS) 2,300, Interface heater temperature (IHT)
160°C for the positive ionization mode, with a mass tol-
erance set to 100 mDa. Analyst (version 2.0) was used
for data acquisition and LC-MS operations. A full mass
scan (MS1) was obtained with a resolution between
9,000-12,000. One scan cycle of seven seconds included
one MS scan from m/z 350-2000 and five MS/MS scans
that are triggered by information dependent acquisition
(IDA) to acquire for MS/MS information on five most
intense precursor ions ranging from m/z 50 to 2000.
Information dependent acquisition enables the “on-
the-fly” acquisition of MS/MS spectra during a chroma-
togram run, in which an MS survey scan is used to gen-
erate peak list of all ions (precursor ions) and only ions
that meet the defined criteria, such as threshold inten-
sity, m/z range and charge state, etc., are subjected for
MS/MS. The QTOF-MS with IDA setup enables acqui-
sition of both TOF MS1- survey scan as well as MS/
MS- product ions scan. This cycle is repeated through-
out the duration of acquisition. IDA experiment moni-
tors five most intense peaks that exceed 25 counts in
intensity with charge state +2 to +4 and mass tolerance
100 ppm. Former target ions were excluded for 30 s.
Automatic collision energy and MS/MS accumulation
were also applied during MS/MS acquisition. Ions of
MassPrep peptides were added to an inclusion list under
IDA mode to trigger the acquisition of their MS/MS
spectra. Based on previous runs, the MassPrep peptides
detected in TOF MS survey scan could not be selected
for MS/MS analysis due to their low signal intensities
and presence of co-eluting serum peptides. However, by
including MassPrep peptide ions into the inclusion list
in IDA acquisition, MS/MS information of spike-in pep-
tides could be obtained for the purpose of later identifi-
cation. For each batch of samples, the inclusion list was
prepared based on one injection of MassPrep peptides
run at the beginning of a batch.
It is important to note that while spectral comparison
was primarily done at MS1 level, MS/MS data were not
needed for comparison purposes. However, MS/MS
information was used for assigning identification to sig-
nificant features, later in the analysis. Peptides identified
with a > 90% confidence level were retained on the list.
This file was imported into the Inclusion tab of the IDA
method in Analyst software. Both time window of ± 1
min and theoretical m/z value of each peptide were put
on the inclusion list. During a batch run each sample
was followed with four wash cycles to minimize sample
carryover. A 100 fmol E.coli beta-galactosidase digest
was run at the beginning and end of a batch to monitor
the performance of LC-MS acquisition.
The data were searched against the International
Protein Index (IPI) human (version 3.6) database using
Paragon Algorithm in ProteinPilot™ software (version
3.0). Fixed modification was set to carboxymethyl (C)
and variable modification to oxidation of methionine
(M). A cutoff value of 95% confidence or 1% false dis-
covery rate (FDR) was used only when searching raw
data against IPI database via Paragon algorithm. For
Progenesis LC-MS software, a MASCOT search was
done against a custom MassPrep database (MPDB),
containing MassPrep peptides and human protein
sequences with MassPrep sequence similarity. Both
groups (i.e., with and without spike-in peptides) were
searched against MPDB. Compiling a custom MPDB
was necessary as certain MassPrep peptides were not
present in human database, thus reducing the database
search time considerably. MPDB was used in evaluat-
ing the analysis results from Progenesis LC-MS and it
was observed that significant features identified as
MassPrep peptides were assigned to with a high MAS-
COT score.
Analytical tools
We evaluated four software tools: msInspect, MZmine 2,
Progenesis LC-MS, and XCMS. All tools perform the
common steps including peak detection, peak grouping,
alignment, and difference detection. In addition, Progen-
esis LC-MS allows peptide identification by analysis of
tandem MS (MS/MS) data. All tools except XCMS pro-
vide solutions to identify charge states and isotopic pat-
terns. Detected features were further filtered to retain
those present in at least two replicates in each group for
statistical analysis.
The main workflow in msInspect (version 2.3, build
599) is composed of three modules called findpeptides,
filter, and peptidearray [23]. It starts with peak detection
followed by deisotoping and charge state recognition.
Based on demands of users, the detected features can be
further filtered by intensity, m/z range, or scan range.
The features are then aligned and grouped across sam-
ples by the peptidearray module. Alignment is based on
either splines or quantile regression and is only applied
to features of identical charge states. The selected para-
meters are summarized as follows: FeatureStrategy-
PeakClusters and walkSmoothed options were selected
for findpeptides module; minIntensity = 15 and min-
Scans = 10 were selected for filter module; quantile
option, minPeaks = 2, minCharge = 1, scanWindow =
125, alignmztolerance = 0.025, and massWindow = 0.1
were selected for peptidearray module.
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Page 9 of 11A workflow composed of peak detection, peak list dei-
sotoping, alignment, peak row filtering and gap filling is
carried out in MZmine 2 [24]. The peak detection is
performed by linking intense ions with similar m/z
across successive scans to build chromatograms. The
deconvolution algorithm is then applied to each chro-
matogram to recognize individual chromatographic
peaks. With specified m/z and retention time tolerances,
the alignment can be carried out with either linear or
nonlinear correction. The parameters for each prepro-
cessing step in MZmine 2 are summarized as follows.
For each LC-MS run, noise level of 2.5, minimum inten-
sity of 5, retention time span of 10 s, and m/z tolerance
of 0.1 Da were selected for peak detection and filtering
purpose; maximum charge of 6, retention time tolerance
o f3s ,a n dm/z tolerance of 0.03 Da were selected for
deisotoping. Feature alignment across runs was based
on the parameters: m/z t o l e r a n c eo f0 . 0 5D aa n dr e t e n -
tion time tolerance of 1.5 min. Gap filling for missing
value imputation was then applied to the detected
features.
Progenesis LC-MS generates an aggregate run con-
taining the peptide ions from all analyzed runs. Semi-
supervised alignment is achieved by choosing a refer-
ence run and aligning all runs to it based on landmark
vectors. The landmark vector is composed of landmark
points of retention times and m/z values that enable
alignment of all LC-MS runs. In Progenesis LC-MS, the
landmark vector can be generated either automatically
by the software for all LC-MS runs based on detected
paired features (details are not provided by Progenesis)
or can be selected manually by looking at each LC-MS
map. For our study we placed 10 manual points consis-
tently present in all LC-MS runs. After alignment, the
isotopic patterns are identified and irrelevant features
are then filtered out by selecting a retention time range,
charge states and number of isotopes. Even though the
LC run was 240 min, for our analysis we observed most
of the peptides were eluted before 150 min (during the
gradient). The LC-MS map is therefore filtered to retain
features within 150 min of retention time. In spite of
peptides coming out earlier, the LC was run was longer
to segregate serum peptides from junk coming off at >
200 min with high organic. Once filtered the data are
normalized by calculating quantitative abundance ratio
to the reference run. Normalization is based on the
assumption that most proteins do not change, and so
the quantitative abundance ratio should be close to 1.
This is followed by aggregating runs for difference
detection and statistical analysis.
XCMS provides a series of LC-MS data preprocessing
algorithms implemented in R language [26] and is help-
ful to assess performance at each preprocessing step.
The peak detection is performed on overlaid extracted
ion chromatograms by a pattern matching approach,
with kernel of Gaussian or second derivative of Gaus-
sian. After peak detection, peaks that fall within a pre-
defined range are grouped together and better grouped
peaks are identified as “well-behaved” peaks for align-
ment purpose. Alignment is preceded by applying med-
ium filter and local regressor. Since XCMS was
developed for metabolomics study, several issues related
to proteomics study such as charge state selection and
isotopic pattern identification are not addressed. The
parameters for each preprocessing step in XCMS are
summarized as follows. For peak detection, the matched
filter algorithm with parameters fwhm = 30, snthresh =
1 0 ,p r o f s t e p=0 . 1 ,a n da ni n t e n s i t yt h r e s h o l do f5w a s
used. Retention time correction was performed two
times with peak grouping in between with bw = 30,
mzwid = 0.1 after first retention time correction and bw
= 15, mzwid = 0.1 after the second retention time
correction.
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